ESR2 and breast cancer: Resveratrol is particularly important for breast cancer since it has been shown to exert both estrogenic or antiestrogenic effects and binds to estrogen receptors ERα and ERβ with comparable affinity, but with 7,000-fold lower affinity than estrogen[6-8].